MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Manufacturer recommends storing in original container. Protect from light. Anecdotal reports of use in MCAs (low quality evidence).

Provenance

This recommendation is based on the products Zyloric 300mg tablets (Aspen) and Allopurinol 300mg (Ipca Laboratories Ltd) and Allopurinol 200mg tablets (Aspire Pharma).

Stability Notes

Manufacturer recommends storing in original container. Protect from light. Anecdotal reports of use in MCAs (low quality evidence).

Provenance

This recommendation is based on the products Zyloric 300mg tablets (Aspen) and Allopurinol 300mg (Ipca Laboratories Ltd) and Allopurinol 200mg tablets (Aspire Pharma).

Stability Notes

Manufacturer recommends storing in original container. Protect from light. Anecdotal reports of use in MCAs (low quality evidence).

Provenance

This recommendation is based on the products Zyloric 300mg tablets (Aspen) and Allopurinol 300mg (Ipca Laboratories Ltd) and Allopurinol 200mg tablets (Aspire Pharma).

Stability Notes

Manufacturer recommends storing in original container. Protect from light. Anecdotal reports of use in MCAs (low quality evidence).

Provenance

This recommendation is based on the products Zyloric 300mg tablets (Aspen) and Allopurinol 300mg (Ipca Laboratories Ltd) and Allopurinol 200mg tablets (Aspire Pharma).

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Vipdomet 12.5mg/1000mg tablets (Takeda UK Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA, however mitigations may need to be considered.
Medicines under this category are not suitable for use in MCAs.
These medicines have not been reviewed by SPS.